• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

巴基斯坦分离的 HCV E1 蛋白的结构分析和表位预测:一种计算机方法。

Structural analysis and epitope prediction of HCV E1 protein isolated in Pakistan: an in-silico approach.

机构信息

Department of Bioinformatics and Biotechnology, Government College University (GCU), Faisalabad, Pakistan.

出版信息

Virol J. 2013 Apr 10;10:113. doi: 10.1186/1743-422X-10-113.

DOI:10.1186/1743-422X-10-113
PMID:23575359
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3637199/
Abstract

BACKGROUND

HCV infection is a major health problem causing acute and chronic hepatitis. HCV E1 protein is a transmembrane protein that is involved in viral attachment and therefore, can serve as an important target for vaccine development. Consequently, this study was designed to analyze the HCV E1 protein sequence isolated in Pakistan to find potential conserved epitopes/antigenic determinants.

RESULTS

HCV E1 protein isolated in Pakistan was analyzed using various bio-informatics and immuno-informatics tools including sequence and structure tools. A total of four antigenic B cell epitopes, 5 MHC class I binding peptides and 5 MHC class II binding peptides were predicted. Best designed epitopes were subjected to conservation analyses with other countries.

CONCLUSION

The study was conducted to predict antigenic determinants/epitopes of HCV E1 protein of genotype 3a along with the 3D protein modeling. The study revealed potential B-cell and T-cell epitopes that can raise the desired immune response against HCV E1 protein isolated in Pakistan. Conservation analysis can be helpful in developing effective vaccines against HCV and thus limiting threats of HCV infection in Pakistan.

摘要

背景

HCV 感染是一个主要的健康问题,可导致急性和慢性肝炎。HCV E1 蛋白是一种跨膜蛋白,参与病毒附着,因此可以作为疫苗开发的重要靶点。因此,本研究旨在分析在巴基斯坦分离的 HCV E1 蛋白序列,以寻找潜在的保守表位/抗原决定簇。

结果

使用各种生物信息学和免疫信息学工具,包括序列和结构工具,对在巴基斯坦分离的 HCV E1 蛋白进行了分析。共预测了四个抗原 B 细胞表位、5 个 MHC Ⅰ类结合肽和 5 个 MHC Ⅱ类结合肽。最佳设计的表位与其他国家进行了保守性分析。

结论

本研究旨在预测基因型 3a 的 HCV E1 蛋白的抗原决定簇/表位,并进行 3D 蛋白建模。研究揭示了潜在的 B 细胞和 T 细胞表位,可以针对在巴基斯坦分离的 HCV E1 蛋白引起所需的免疫反应。保守性分析有助于开发针对 HCV 的有效疫苗,从而限制 HCV 感染在巴基斯坦的威胁。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa91/3637199/3c24b402aa98/1743-422X-10-113-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa91/3637199/354afe0e649c/1743-422X-10-113-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa91/3637199/a975f638d877/1743-422X-10-113-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa91/3637199/6af5656f1ca6/1743-422X-10-113-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa91/3637199/3c24b402aa98/1743-422X-10-113-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa91/3637199/354afe0e649c/1743-422X-10-113-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa91/3637199/a975f638d877/1743-422X-10-113-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa91/3637199/6af5656f1ca6/1743-422X-10-113-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa91/3637199/3c24b402aa98/1743-422X-10-113-4.jpg

相似文献

1
Structural analysis and epitope prediction of HCV E1 protein isolated in Pakistan: an in-silico approach.巴基斯坦分离的 HCV E1 蛋白的结构分析和表位预测:一种计算机方法。
Virol J. 2013 Apr 10;10:113. doi: 10.1186/1743-422X-10-113.
2
HCV Envelope protein 2 sequence comparison of Pakistani isolate and In-silico prediction of conserved epitopes for vaccine development.巴基斯坦分离株 HCV 包膜蛋白 2 序列比较和用于疫苗开发的保守表位的计算机预测。
J Transl Med. 2013 Apr 30;11:105. doi: 10.1186/1479-5876-11-105.
3
Promiscuous prediction and conservancy analysis of CTL binding epitopes of HCV 3a viral proteome from Punjab Pakistan: an in silico approach.巴基斯坦旁遮普地区丙型肝炎病毒 3a 病毒蛋白组 CTL 结合表位的混杂预测和保护分析:一种计算机方法。
Virol J. 2011 Feb 8;8:55. doi: 10.1186/1743-422X-8-55.
4
Hepatitis C Virus Subtype 3a Envelope Protein 1 Binding with Human Leukocyte Antigen Class I Types of Pakistani Population: Candidate Epitopes for Synthetic Peptide Vaccine.丙型肝炎病毒3a亚型包膜蛋白1与人白细胞抗原I类在巴基斯坦人群中的结合:合成肽疫苗的候选表位
Iran J Allergy Asthma Immunol. 2015 Oct;14(5):526-34.
5
Expression, immunogenicity and diagnostic value of envelope proteins from an Egyptian hepatitis C virus isolate.埃及丙型肝炎病毒分离株包膜蛋白的表达、免疫原性及诊断价值
Arch Virol. 2015 Apr;160(4):945-58. doi: 10.1007/s00705-015-2334-1. Epub 2015 Jan 29.
6
Reverse vaccinology approach for identification of epitopes from E1 protein as peptide vaccine against HCV: A proof of concept.反向疫苗学方法鉴定 HCV E1 蛋白表位作为 HCV 肽疫苗:概念验证。
Vaccine. 2024 Oct 24;42(24):126106. doi: 10.1016/j.vaccine.2024.07.007. Epub 2024 Jul 8.
7
A novel combined vaccine candidate containing epitopes of HCV NS3, core and E1 proteins induces multi-specific immune responses in BALB/c mice.一种包含丙型肝炎病毒NS3、核心和E1蛋白表位的新型联合疫苗候选物在BALB/c小鼠中诱导多特异性免疫反应。
Antiviral Res. 2009 Oct;84(1):23-30. doi: 10.1016/j.antiviral.2009.07.011. Epub 2009 Jul 29.
8
Broad Spectrum Peptide Vaccine Design Against Hepatitis C Virus.抗丙型肝炎病毒的广谱肽疫苗设计
Curr Comput Aided Drug Des. 2019;15(2):120-135. doi: 10.2174/1573409914666181003151222.
9
De Novo modeling of Envelope 2 protein of HCV isolated from Pakistani patient and epitopes prediction for vaccine development.对从巴基斯坦患者分离出的丙型肝炎病毒包膜2蛋白进行从头建模及疫苗开发的表位预测。
J Transl Med. 2014 May 7;12:115. doi: 10.1186/1479-5876-12-115.
10
Approaching rational epitope vaccine design for hepatitis C virus with meta-server and multivalent scaffolding.利用元服务器和多价支架技术进行丙型肝炎病毒合理表位疫苗设计
Sci Rep. 2015 Aug 4;5:12501. doi: 10.1038/srep12501.

引用本文的文献

1
HCV immunodominant peptide mapping reveals unique HLA-A*02-restricted signatures: insights for CD8 T-cell-based vaccines and immunotherapies.丙型肝炎病毒免疫显性肽图谱揭示独特的HLA-A*02限制性特征:对基于CD8 T细胞的疫苗和免疫疗法的启示
Immunogenetics. 2025 Jan 31;77(1):13. doi: 10.1007/s00251-025-01370-2.
2
Immunoinformatics approach for predicting epitopes in HN and F proteins of Porcine rubulavirus.猪 rubulavirus 的 HN 和 F 蛋白中抗原表位的免疫信息学预测方法。
PLoS One. 2020 Sep 25;15(9):e0239785. doi: 10.1371/journal.pone.0239785. eCollection 2020.
3
Epitope-Based Peptide Vaccine against Glycoprotein G of Nipah Using Immunoinformatics Approaches.

本文引用的文献

1
Reliable B cell epitope predictions: impacts of method development and improved benchmarking.可靠的 B 细胞表位预测:方法开发和改进基准测试的影响。
PLoS Comput Biol. 2012;8(12):e1002829. doi: 10.1371/journal.pcbi.1002829. Epub 2012 Dec 27.
2
A brief review on dengue molecular virology, diagnosis, treatment and prevalence in Pakistan.巴基斯坦登革热分子病毒学、诊断、治疗及流行情况简述
Genet Vaccines Ther. 2012 Aug 28;10(1):6. doi: 10.1186/1479-0556-10-6.
3
Inhibition of hepatitis C virus 3a genotype entry through Glanthus Nivalis Agglutinin.
基于表位的尼帕病毒糖蛋白 G 肽疫苗:免疫信息学方法。
J Immunol Res. 2020 Apr 22;2020:2567957. doi: 10.1155/2020/2567957. eCollection 2020.
4
A multiepitopic theoretical fusion construct based on in-silico epitope screening of known vaccine candidates for protection against wide range of enterobacterial pathogens.一种基于已知疫苗候选物的计算机模拟表位筛选的多表位理论融合构建体,用于预防广泛的肠杆菌病原体感染。
Hum Immunol. 2019 Jul;80(7):493-502. doi: 10.1016/j.humimm.2019.02.008. Epub 2019 Feb 12.
5
Structural and Epitope Analysis (T- and B-Cell Epitopes) of Hepatitis C Virus (HCV) Glycoproteins: An Approach.丙型肝炎病毒(HCV)糖蛋白的结构与表位分析(T细胞和B细胞表位):一种方法
J Clin Exp Hepatol. 2018 Dec;8(4):352-361. doi: 10.1016/j.jceh.2017.12.010. Epub 2018 Feb 21.
6
Peptide vaccine against chikungunya virus: immuno-informatics combined with molecular docking approach.针对基孔肯雅病毒的肽疫苗:免疫信息学与分子对接方法的结合。
J Transl Med. 2018 Oct 27;16(1):298. doi: 10.1186/s12967-018-1672-7.
7
Progress and challenges in predicting protein interfaces.预测蛋白质界面的进展与挑战。
Brief Bioinform. 2016 Jan;17(1):117-31. doi: 10.1093/bib/bbv027. Epub 2015 May 13.
8
A comprehensive immunoinformatics and target site study revealed the corner-stone toward Chikungunya virus treatment.一项全面的免疫信息学和靶点研究揭示了基孔肯雅病毒治疗的基石。
Mol Immunol. 2015 May;65(1):189-204. doi: 10.1016/j.molimm.2014.12.013. Epub 2015 Feb 14.
9
Diagnostic tests for hepatitis C: recent trends in electrochemical immunosensor and genosensor analysis.丙型肝炎的诊断测试:电化学免疫传感器和基因传感器分析的最新趋势
World J Gastroenterol. 2014 Nov 14;20(42):15476-91. doi: 10.3748/wjg.v20.i42.15476.
10
HCV Envelope protein 2 sequence comparison of Pakistani isolate and In-silico prediction of conserved epitopes for vaccine development.巴基斯坦分离株 HCV 包膜蛋白 2 序列比较和用于疫苗开发的保守表位的计算机预测。
J Transl Med. 2013 Apr 30;11:105. doi: 10.1186/1479-5876-11-105.
通过雪绒花凝集素抑制丙型肝炎病毒 3a 基因型进入。
Virol J. 2011 May 20;8:248. doi: 10.1186/1743-422X-8-248.
4
An overview of HCV molecular biology, replication and immune responses.丙型肝炎病毒分子生物学、复制和免疫应答概述。
Virol J. 2011 Apr 11;8:161. doi: 10.1186/1743-422X-8-161.
5
In-vitro model systems to study Hepatitis C Virus.用于研究丙型肝炎病毒的体外模型系统。
Genet Vaccines Ther. 2011 Apr 6;9:7. doi: 10.1186/1479-0556-9-7.
6
Post-transcriptional inhibition of hepatitis C virus replication through small interference RNA.通过小干扰 RNA 抑制丙型肝炎病毒复制的转录后机制。
Virol J. 2011 Mar 10;8:112. doi: 10.1186/1743-422X-8-112.
7
Hepatitis C treatment: current and future perspectives.丙型肝炎治疗:现状和未来展望。
Virol J. 2010 Nov 1;7:296. doi: 10.1186/1743-422X-7-296.
8
Hepatitis C in Pakistan: magnitude, genotype, disease characteristics and therapeutic response.巴基斯坦的丙型肝炎:流行程度、基因型、疾病特征及治疗反应
Trop Gastroenterol. 2008 Oct-Dec;29(4):194-201.
9
Hepatitis C virus cell entry: role of lipoproteins and cellular receptors.丙型肝炎病毒的细胞进入:脂蛋白和细胞受体的作用
J Gen Virol. 2009 May;90(Pt 5):1055-1070. doi: 10.1099/vir.0.008300-0. Epub 2009 Mar 4.
10
Frequency distribution of hepatitis C virus genotypes in different geographical regions of Pakistan and their possible routes of transmission.巴基斯坦不同地理区域丙型肝炎病毒基因型的频率分布及其可能的传播途径。
BMC Infect Dis. 2008 May 23;8:69. doi: 10.1186/1471-2334-8-69.